Concepedia

Susanna Cremonesi

SC

Statistics

Publications

5

Citations

131

H-Index

5

Active since

2010

Affiliations

Indivior (United States)(Current)

Aptuit (Italy)

GlaxoSmithKline (Italy)

Susanna Cremonesi is an author at Indivior (United States) specializing in pharmacology, medicinal chemistry, and neuropharmacology.

Publications per year

2010–2016

5

Publications

5

Pyrrolo[1,2-a]pyrazine and pyrazolo[1,5-a]pyrazine: Novel, potent, and selective series of Vasopressin1b receptor antagonists

Roberto Arban, Federica Bianchi, Alberto Buson et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 42 citations · Full text

, , +11

Exploration of the Amine Terminus in a Novel Series of 1,2,4-Triazolo-3-yl-azabicyclo[3.1.0]hexanes as Selective Dopamine D<sub>3</sub>Receptor Antagonists

Fabrizio Micheli, Luca Arista, Barbara Bertani et al. · Journal of Medicinal Chemistry · 2010 · 27 citations · Full text

, , +15

Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists

Fabrizio Micheli, Susanna Cremonesi, Teresa Semeraro et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 22 citations · Full text

, , +14

1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists

Fabrizio Micheli, Andrea Bernardelli, Federica Bianchi et al. · Bioorganic & Medicinal Chemistry · 2016 · 20 citations · Full text

, , +11

1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists

Fabrizio Micheli, Alessia Bacchi, Simone Braggio et al. · Journal of Medicinal Chemistry · 2016 · 20 citations · Full text

, , +17

1–5 of 5